Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension.
about
Role of endothelin in uteroplacental circulation and fetal vascular functionClinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension.Endothelin antagonism as an active principle for glaucoma therapyEffect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.Evaluation of the effect of ambrisentan on digital microvascular flow in patients with systemic sclerosis using laser Doppler perfusion imaging: a 12-week randomized double-blind placebo controlled trial.Endothelin: key mediator of hypertension in preeclampsia.Linking placental ischemia and hypertension in preeclampsia: role of endothelin 1.Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia.The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia.Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension.New pharmacotherapy options for pulmonary arterial hypertension.Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT(1) and ET(A) receptor antagonists.Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition.The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia.
P2860
Q26828020-6024BDB0-B73B-45FF-BB6D-733A68D7AF49Q33161210-E221A7FA-32A0-47F6-991B-5A876B1C9B19Q34588644-5ED43BAC-3AF2-4E0B-AE00-EB50E02A7050Q34721485-40C42F43-1EC1-47FD-8D2F-5D7E923A015BQ35256824-288D98B6-9E49-4B86-BD35-CBC2864ECA31Q36073225-5460F24A-6A86-45B7-952F-C70816BC456CQ36106483-FD8DA25B-3DD4-4D50-9D58-8BD9151541B7Q37451322-C90B9DA4-6FB1-4A39-BB3A-775EA4B77A90Q37729072-B8BC6EFB-CC1D-4E8B-87E0-67A34291FA6DQ37866804-F0D11728-5607-44F7-AE3A-9887929C40CBQ38569940-15E06AB2-5A9E-4917-8702-393E4FDAD706Q39015639-DA9EA970-B2D7-4AD2-814F-847E0662037BQ43055099-C8CAA67F-C34A-4F9F-B59B-642C70901087Q52594781-F6C63C31-9C55-4FE4-84ED-FADA2FE15BCF
P2860
Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ambrisentan, an endothelin rec ...... lmonary arterial hypertension.
@en
Ambrisentan, an endothelin rec ...... lmonary arterial hypertension.
@nl
type
label
Ambrisentan, an endothelin rec ...... lmonary arterial hypertension.
@en
Ambrisentan, an endothelin rec ...... lmonary arterial hypertension.
@nl
prefLabel
Ambrisentan, an endothelin rec ...... lmonary arterial hypertension.
@en
Ambrisentan, an endothelin rec ...... lmonary arterial hypertension.
@nl
P2093
P2860
P1476
Ambrisentan, an endothelin rec ...... lmonary arterial hypertension.
@en
P2093
Fernando Torres
Martha Kingman
Rosechelle Ruggiero
P2860
P304
P356
10.1517/14656560903061275
P407
P577
2009-08-01T00:00:00Z